Published in Curr Opin Immunol on October 01, 2011
Advances in human B cell phenotypic profiling. Front Immunol (2012) 1.41
Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol (2012) 1.01
Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J Clin Invest (2014) 0.99
Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88
mTOR has distinct functions in generating versus sustaining humoral immunity. J Clin Invest (2016) 0.84
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats. Clin Exp Immunol (2015) 0.82
CD28 family and chronic rejection: "to belatacept...And beyond!". J Transplant (2012) 0.82
Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance. Stem Cells Dev (2014) 0.81
Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells. Immunology (2014) 0.81
Diversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft model. Sci Rep (2015) 0.80
Lymphodepletional strategies in transplantation. Cold Spring Harb Perspect Med (2013) 0.78
Common and small molecules as the ultimate regulatory and effector mediators of antigen-specific transplantation reactions. World J Transplant (2013) 0.75
Pretransplant infusion of donor B cells enhances donor-specific skin allograft survival. PLoS One (2013) 0.75
Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice. Immunogenetics (2013) 0.75
B cells regulate autoimmunity by provision of IL-10. Nat Immunol (2002) 7.30
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med (2009) 6.89
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science (2001) 5.73
Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol (2006) 5.22
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity (2010) 5.13
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity (2002) 4.60
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity (2004) 4.42
Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35
Prevention of arthritis by interleukin 10-producing B cells. J Exp Med (2003) 4.27
B cells turn off virgin but not memory T cells. Science (1992) 4.12
Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59
Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol (2010) 3.56
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med (2008) 2.99
Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol (2011) 2.83
B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med (2009) 2.56
Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol (2008) 2.38
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant (2006) 2.37
Sites and stages of autoreactive B cell activation and regulation. Immunity (2008) 2.31
Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol (2011) 2.31
Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood (2007) 2.21
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet (2005) 2.02
Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med (2004) 1.92
A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation. Transplantation (2009) 1.79
Plasma cell development: from B-cell subsets to long-term survival niches. Semin Immunol (2008) 1.68
Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant (2007) 1.60
TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol (2005) 1.56
Space, selection, and surveillance: setting boundaries with BLyS. J Immunol (2006) 1.55
B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med (2007) 1.53
Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol (2007) 1.47
Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol (2009) 1.43
B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol (2006) 1.34
Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys. J Clin Invest (2010) 1.16
In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol (2008) 1.14
Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells. J Immunol (2007) 1.02
B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol (2011) 0.98
The role of B lymphocytes as antigen-presenting cells. Arch Immunol Ther Exp (Warsz) (2008) 0.96
Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness. J Immunol (2003) 0.93
Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood (2010) 0.92
The generation and maintenance of serum alloantibody. Curr Opin Immunol (2010) 0.88
Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age? Am J Transplant (2009) 0.86
Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci U S A (2007) 0.85
Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes. J Immunol (2010) 0.83
The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo. Transplantation (2011) 0.82
B-cell tolerance in transplantation: is repertoire remodeling the answer? Expert Rev Clin Immunol (2009) 0.80
B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplant Rev (Orlando) (2010) 0.79
Emerging role of B cells in chronic allograft dysfunction. Kidney Int Suppl (2010) 0.78
Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients. Transplantation (2009) 0.78
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
A model of structure and catalysis for ketoreductase domains in modular polyketide synthases. Biochemistry (2003) 2.65
Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol (2009) 2.48
Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest (2013) 2.38
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med (2002) 2.29
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes (2004) 2.22
Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting. Diabetes (2013) 1.90
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med (2007) 1.53
Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res (2010) 1.51
Graft and patient survival outcomes of a third kidney transplant. Transplantation (2015) 1.41
Avoiding tracheostomy: submental intubation in faciomaxillary trauma surgery. Plast Reconstr Surg (2004) 1.39
B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol (2006) 1.34
Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation (2003) 1.32
{beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes (2005) 1.28
Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes (2003) 1.27
Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes (2003) 1.25
Retracted A genome-wide regulatory framework identifies maize pericarp color1 controlled genes. Plant Cell (2012) 1.19
Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin Cancer Res (2003) 1.18
Research resource: the pdx1 cistrome of pancreatic islets. Mol Endocrinol (2012) 1.17
Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes (2005) 1.16
Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes (2013) 1.15
Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15
RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J Exp Med (2008) 1.14
In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol (2008) 1.14
Overexpression of hepatocyte nuclear factor-4α initiates cell cycle entry, but is not sufficient to promote β-cell expansion in human islets. Mol Endocrinol (2012) 1.13
Multiple pathways for triacylglycerol biosynthesis in Streptomyces coelicolor. Appl Environ Microbiol (2008) 1.11
Calcineurin signaling regulates human islet {beta}-cell survival. J Biol Chem (2010) 1.09
MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells. Diabetes (2012) 1.08
Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab (2006) 1.07
Ethics in psychosocial and biomedical research - A training experience at the Interdisciplinary Center for Bioethics (CIEB) of the University of Chile(). Acta Bioeth (2012) 1.05
Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab (2006) 1.04
{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab (2010) 1.04
The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 1.03
Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am J Physiol Endocrinol Metab (2011) 1.03
Targeting the cell cycle inhibitor p57Kip2 promotes adult human β cell replication. J Clin Invest (2014) 1.02
Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation. J Immunol (2003) 1.01
Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine. J Biol Chem (2012) 1.00
Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation (2002) 0.99
Acute insulin responses to glucose and arginine as predictors of beta-cell secretory capacity in human islet transplantation. Transplantation (2007) 0.99
HLA sensitization in islet transplantation. Clin Transpl (2006) 0.97
Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J Immunol (2006) 0.97
Islet transplantation in type I diabetes mellitus. Yale J Biol Med (2012) 0.96
Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab (2007) 0.96
CD4+ T cells recognizing a single self-peptide expressed by APCs induce spontaneous autoimmune arthritis. J Immunol (2008) 0.96
Glucokinase activators for diabetes therapy: May 2010 status report. Diabetes Care (2011) 0.96
Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol (2002) 0.96
Arterialized venous flow-through flap for simultaneous reconstruction of a radial artery defect and palmar forearm soft-tissue loss from sarcoma resection. J Reconstr Microsurg (2005) 0.95
Increased early graft failure in right-sided living donor nephrectomy. Transplantation (2011) 0.95
Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation. Nephrol Dial Transplant (2007) 0.92
PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol Immunol (2008) 0.91
Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation. Transplantation (2004) 0.91
One-dimensional counterion gas between charged surfaces: exact results compared with weak- and strong-coupling analyses. J Chem Phys (2009) 0.90
Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients. J Clin Endocrinol Metab (2008) 0.90
Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic beta-cells. Diabetes (2006) 0.89
Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes (2003) 0.88
LIM domain-binding 1 maintains the terminally differentiated state of pancreatic β cells. J Clin Invest (2016) 0.87
Identification of a bifunctional maize C- and O-glucosyltransferase. J Biol Chem (2013) 0.87
Counterion-mediated weak and strong coupling electrostatic interaction between like-charged cylindrical dielectrics. J Chem Phys (2010) 0.86
Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF. Transplantation (2012) 0.86
Delays in the human heartbeat dynamics. Chaos (2009) 0.86
Long-term impact of damage control laparotomy: a prospective study. Arch Surg (2010) 0.85
Inferior allograft outcomes in adolescent recipients of renal transplants from ideal deceased donors. Ann Surg (2012) 0.85
A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4+ iNKT cell deficient state. Immunogenetics (2010) 0.85
Improved bioconversion of 15-fluoro-6-deoxyerythronolide B to 15-fluoro-erythromycin A by overexpression of the eryK Gene in Saccharopolyspora erythraea. Biotechnol Prog (2004) 0.84
Dressed counterions: strong electrostatic coupling in the presence of salt. J Chem Phys (2010) 0.84
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest (2017) 0.83
Underutilization of A2 ABO incompatible kidney transplantation. Clin Transplant (2011) 0.83
Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes. J Immunol (2010) 0.83
Beta-cell imaging: opportunities and limitations. J Nucl Med (2011) 0.83
Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival. Transplantation (2009) 0.83
Comparison study of acellular dermal matrices in complicated hernia surgery. J Am Coll Surg (2013) 0.83
Salt-induced counterion-mobility anomaly in polyelectrolyte electrophoresis. Phys Rev Lett (2008) 0.83
Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice. Int Immunol (2002) 0.82
Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion. Indian J Ophthalmol (2012) 0.82
The role of t/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses. Immunol Res (2003) 0.82
Contrast-enhanced MR angiography for evaluation of vascular complications of the pancreatic transplant. Radiographics (2005) 0.81
Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model. Endocrinology (2012) 0.81
Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab (2013) 0.81
Salt-modulated structure of polyelectrolyte-macroion complex fibers. Eur Phys J E Soft Matter (2011) 0.80
B-cell tolerance in transplantation: is repertoire remodeling the answer? Expert Rev Clin Immunol (2009) 0.80
Buccinator myomucosal island flap for postablative maxillofacial reconstructions: a report of 4 cases. J Oral Maxillofac Surg (2002) 0.79
B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplant Rev (Orlando) (2010) 0.79
Specialized CC-chemokine secretion by Th1 cells in destructive autoimmune myocarditis. J Autoimmun (2003) 0.79